As of the writing of this article, only one product, MiSight 1 day contact lens from CooperVision, is FDA approved for slowing the progression of myopia in children. This is long-awaited great news for eyecare practitioners, as it adds to the science and credibility of myopia management, especially when talking to parents. Of course, other means of treating childhood myopia (different soft multifocal contact lenses, topical low-dose atropine, orthokeratology lenses, and eyeglasses) are available but not yet FDA approved. How exactly does this impact your myopia management practice, if at all? Read More